| INTRODUCTION
A major challenge in evaluating patients with eosinophilia is that many diseases associated with secondary, or reactive, eosinophilia are themselves difficult to diagnose. Immunoglobulin G4-related disease (IgG4-RD) is an emerging condition associated with reactive eosinophilia in one-third of patients. 1 Common clinical manifestations include dacryoadenitis, sialadenitis, lymphadenopathy, autoimmune pancreatitis, and retroperitoneal fibrosis, although nearly any organ except joints and brain parenchyma can be involved. Forty percent of patients have associated asthma or atopy, often with elevated IgE, although the eosinophilia and increased IgE appear inherent to the IgG4-RD rather than atopic disease. 1,2 Most patients have elevated serum IgG4 often accompanied by elevated total IgG and polyclonal hypergammaglobulinemia on serum protein electrophoresis. 3 Oligoclonal expansion of CD4 + T effector memory (T EM ) lymphocytes has been detected using next-generation sequencing and is thought to drive the pathophysiology and in particular the fibrosis seen in this disease. 4 Despite the protean clinical manifestations, histopathologic features from nearly any organ are similar, and diagnosis of IgG4-RD requires histologic findings including a polyclonal lymphoplasmacytic infiltrate, storiform fibrosis, obliterative phlebitis, and increased IgG4 + plasma cells. 3 Treatments for IgG4-RD include glucocorticoids and rituximab. 
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Like IgG4-RD, L-HES is commonly treated initially with glucocorticoids. 7 The natural history is generally indolent, but some patients may develop aggressive T-cell lymphoma.
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The gold standard for diagnosis of IgG4-RD is histopathology, in keeping with the International Consensus Criteria, with corresponding clinical, laboratory, and radiological features. 12 Diagnostic criteria for L-HES are not as strictly defined as for IgG4-RD, nor are there a widely accepted set of consensus criteria, but usually involve a combination of clinical findings, hypereosinophilia, immunophenotyping, and T-cell clonality studies. 13 Given that IgG4-RD and L-HES present with overlapping clinical and laboratory features such as asthma, atopy, lymphadenopathy, eosinophilia, and elevated serum immunoglobulins, differentiating between these two rare entities is an underappreciated diagnostic challenge. 14, 15 We previously published the case of a young woman with polyclonal hyperviscosity syndrome and eosinophilia labeled as idiopathic HES, a diagnosis confirmed prior to publication by international experts in eosinophilia (case I3 in this study); 16 however, 2 years after publication, she was found to have histologically confirmed IgG4-RD. 17 Given the potential diagnostic confusion between these two entities, and the lack of large studies comparing them, we conducted a comparative case series describing the clinical and laboratory features of patients with
IgG4-RD and L-HES. This is the first study to report T-cell immunophenotyping and T-cell clonality testing in a large number of patients with IgG4-RD and the first report of serum IgG4 levels in a large number of patients with L-HES. 
| MATERIALS AND METHODS

| RESULTS
| Patients
Clinical data for patients with IgG4-RD and L-HES are shown in Table 1 
IgG4-RD (n=31) L-HES (n=13) P
| Organ involvement
Patients with IgG4-RD had more organs involved than those with L-HES (median 5 vs 3, P=.029). There were no differences in constitutional symptoms including weight loss, fevers, night sweats, and fatigue, although two patients with IgG4-RD had polyclonal hypergammaglobulinemic hyperviscosity syndrome. The most commonly involved organs in IgG4-RD were the submandibular glands, lymph nodes, and lacrimal glands, all of which were more frequently affected than in patients with L-HES (Table 1 ). In patients with L-HES, the most common symptomatic organs were skin, lungs, lymph nodes, and gastrointestinal tract; salivary and lacrimal glands were not a concern. (not to be confused with myelofibrosis) are not seen in bone marrow specimens and lymph node specimens. All 10 of the patients with L-HES who had bone marrow biopsies had marrow involvement with eosinophilia ( Figure 2 ).
| Histopathologic features
| Laboratory findings
Laboratory findings are summarized in Table 2 and Table 3 . HES to IgG4-RD also highlights the lack of widely accepted diagnostic criteria for L-HES, a rare condition wherein flow cytometry is considered the gold standard, 25 yet T-cell clonality by PCR is sometimes used as a surrogate. 29 However, the main strength of this study is that it describes for the first time the potential diagnostic overlap between these two diseases using commonly available laboratory tests 
| Treatment
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